Plain-English translation of NCT06821464 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
Researchers studied , a new oral medication, to understand how safe it is and how the body processes it when taken repeatedly. The trial involved healthy volunteers who received either a lower or higher dose of the medication. The goal was to gather early safety information before the medication could potentially be tested in patients with lung conditions.
Before any new medication can be tested in patients who are actually sick, researchers need to first confirm that it is safe and well-tolerated in healthy people. This early-stage trial provided that foundation of safety data.
Participants were divided into two groups and received either a lower or higher dose of the medication taken by mouth on multiple occasions. Throughout the trial, researchers collected blood samples and performed medical tests to monitor how the body absorbed, processed, and eliminated the medication, as well as to watch for any side effects. Participants made regular visits to the clinic for check-ups and safety monitoring during and after the treatment period.
AI-generated summary from trial data · Jul 14, 2026 · Not medical advice
China
Phase
Safety & dosing
Sponsor
Guangdong Hengrui Pharmaceutical Co., Ltd
Enrollment target
~45 participants
Started
February 2025
Primary completion
July 2025
Age range
18 Years – 45 Years
Last updated on clinicaltrials.gov in July 2026.